share_log

Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2022 and Provides Business Update

SEC ·  May 16, 2022 19:55
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.